IAM

NASDAQ Healthcare

Iambic Therapeutics, Inc. - Common Stock

Biotechnology

Iambic Therapeutics, Inc. operates as a biotechnology company that develops therapeutics from its AI discovery platform that optimizes target product profiles and drug candidates in the United States and Internationally. It offers products, such as IAM-1363, a selective HER2 inhibitor; IAM-K1, a KIF18A inhibitor; IAM217 (a KIF18A inhibitor) and IAM-C1, a CDK2/4 inhibitor; and services, including drug discovery platform and molecular superintelligence platform which includes technologies, such as Enchant and NeuralPLexer to design and develop small molecule therapeutics. Iambic Therapeutics, Inc. was formerly known as Entos, Inc. and changed its name to Iambic Therapeutics, Inc. in May 2023. The company was incorporated in 2019 and is based in San Diego, California.

�� 市场数据
价格$14.28
成交量269,547
市值676.88M
52周最高$25.00
52周最低$13.02
Price / Book-1.45
在Yahoo Finance查看 →
🎯 投资策略评分

IAM 在各投资策略中的评分。分数越高，越符合该策略目标。

💰 Dividend Daddy 29/100
高股息率 + 低波动性
🚀 Moon Shot 14/100
高增长潜力（高贝塔 + 超卖）
🔪 Falling Knife 60/100
逆向投资（超卖 + 低于移动均线）
🎈 Over-Hyped 37/100
超买股票（潜在做空标的）
🐋 Institutional Whale 16/100
大盘、机构级别股票
🔍 策略解读

最佳匹配： 🔪 Falling Knife (60/100) — 此策略 逆向投资（超卖 + 低于移动均线）.

评分最低的策略： 🚀 Moon Shot (14/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →

📚 了解更多
本页指标
教育文章
网站资源
在文本中查找 IAM in your text

粘贴任何文章、记录或帖子 — 工具将提取 IAM 以及每一个其他隐藏的股票代码。

试试股票代码提取器 →

免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-10-29.